Anglopharma

Anglopharma has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €504,483 and a net result of €15,526. Equity remains stable across the filed financial years (±2.5% per year). Its solvency ranks better than 88% of 523 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).